Vosaroxin

Vosaroxin
Names

Preferred IUPAC name 7-[(3S,4S)-3-Methoxy-4-(methylamino)pyrrolidin-1-yl]-4-oxo-1-(1,3-thiazol-2-yl)-1,4-dihydro-1,8-naphthyridine-3-carboxylic acid
Other names Voreloxin
Identifiers
CAS Number	175414-77-4 ^checkY
3D model (JSmol)	Interactive image
ChEBI	CHEBI:231651
ChemSpider	8128494
PubChem CID	9952884
UNII	K6A90IIZ19 ^checkY
CompTox Dashboard (EPA)	DTXSID50938662 Edit this at Wikidata
InChI InChI=1S/C18H19N5O4S/c1-19-12-8-22(9-13(12)27-2)14-4-3-10-15(24)11(17(25)26)7-23(16(10)21-14)18-20-5-6-28-18/h3-7,12-13,19H,8-9H2,1-2H3,(H,25,26)/t12-,13-/m0/s1 Key: XZAFZXJXZHRNAQ-STQMWFEESA-N InChI=1/C18H19N5O4S/c1-19-12-8-22(9-13(12)27-2)14-4-3-10-15(24)11(17(25)26)7-23(16(10)21-14)18-20-5-6-28-18/h3-7,12-13,19H,8-9H2,1-2H3,(H,25,26)/t12-,13-/m0/s1 Key: XZAFZXJXZHRNAQ-STQMWFEEBT
SMILES CN[C@H]1CN(C[C@@H]1OC)C2=NC3=C(C=C2)C(=O)C(=CN3C4=NC=CS4)C(=O)O
Properties
Chemical formula	C₁₈H₁₉N₅O₄S
Molar mass	401.44 g·mol⁻¹
Density	1.5±0.1 g/cm³
Pharmacology
ATC code	L01XX53 (WHO )
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). Infobox references

Chemical compound

Vosaroxin (AG-7352, SPC-595, SNS 595, voreloxin) is a topoisomerase II inhibitor causing site-selective DNA damage. It is under phase III clinical trial investigation for acute myelogenous leukemia (AML) and ovarian cancer sponsored by Sunesis.^[1]

Mechanism of action

[edit ]

Vosaroxin is a naphthyridine analog of the anticancer quinolone derivatives (AQDs), a class of compounds that has not been used previously for the treatment of cancer. Topoisomerase II enzymes are essential for the survival of eukaryotic cells. Vosaroxin hinders the reunion of topoisomerase II-induced double-strand breaks at selective sites in DNA, resulting in G2 arrest and cell death by apoptosis.^[2]

References

[edit ]

^ "Vosaroxin". Selleck Chemicals.
^ "Vosaroxin (Formerly Voreloxin)". Sunesis.

v
t
e

Intracellular chemotherapeutic agents / antineoplastic agents (L01)

SPs/MIs
(M phase)

Block microtubule assembly	Vinca alkaloids (Vinblastine ^# Vincristine ^# Vindesine Vinflunine ^§ Vinorelbine ^#)
Block microtubule disassembly	Taxanes (Cabazitaxel Docetaxel ^# Larotaxel Ortataxel ^† Paclitaxel ^# Tesetaxel) Epothilones (Ixabepilone)

DNA replication
inhibitor

DNA precursors/
antimetabolites
(S phase)

Folic acid	Dihydrofolate reductase inhibitor (Aminopterin Methotrexate ^# Pemetrexed Pralatrexate) Thymidylate synthase inhibitor (Pemetrexed Raltitrexed)
Purine	Adenosine deaminase inhibitor (Pentostatin) Halogenated/ribonucleotide reductase inhibitors (Cladribine Clofarabine Fludarabine) Nelarabine Rabacfosadine Thiopurine (Mercaptopurine ^# Tioguanine ^#)
Pyrimidine	Thymidylate synthase inhibitor (Capecitabine ^# Carmofur Doxifluridine Floxuridine Fluorouracil ^# Tegafur (+gimeracil/oteracil)) DNA polymerase inhibitor (Cytarabine ^# +daunorubicin) Ribonucleotide reductase inhibitor (Gemcitabine ^#) Hypomethylating agent (Azacitidine Decitabine)
Deoxyribonucleotide	Ribonucleotide reductase inhibitor (Hydroxycarbamide ^#)

Topoisomerase inhibitors
(S phase)

I	Camptotheca (Belotecan Camptothecin Cositecan ^† Etirinotecan pegol ^† Exatecan Gimatecan Irinotecan ^# Lurtotecan ^‡ Rubitecan ^‡ Silatecan ^§ Topotecan)
II	Podophyllum (Etoposide ^# Teniposide)
II+Intercalation	Anthracyclines (Aclarubicin Amrubicin ^† Daunorubicin ^# (+cytarabine) Doxorubicin ^# Epirubicin Idarubicin Pirarubicin Valrubicin Zorubicin) Anthracenediones (Losoxantrone Mitoxantrone Pixantrone) Amsacrine Bisantrene Crisnatol Menogaril ^§

Crosslinking of DNA
(CCNS)

Alkylating	Nitrogen mustards: Bendamustine ^# Chlormethine Cyclophosphamide ^# (Ifosfamide ^# Trofosfamide) Chlorambucil ^# Melphalan (Melphalan flufenamide) Prednimustine Uramustine Nitrosoureas: Carmustine Fotemustine Lomustine (Semustine) Nimustine Ranimustine Streptozocin Alkyl sulfonates: Busulfan (Mannosulfan Treosulfan) Aziridines: Carboquone Thiotepa Triaziquone Triethylenemelamine
Platinum-based	Carboplatin ^# Cisplatin ^# Dicycloplatin Nedaplatin Oxaliplatin ^# Satraplatin
Nonclassical	Altretamine Hydrazines (Procarbazine ^#) Etoglucid Mitobronitol Pipobroman Triazenes (Dacarbazine ^# Mitozolomide ^§ Temozolomide)
Intercalation	Streptomyces (Dactinomycin ^# Bleomycin ^# Mitomycins Plicamycin)

Photosensitizers/PDT

Other

Enzyme inhibitors	FI (Tipifarnib ^§) CDK inhibitors (Abemaciclib Alvocidib ^† Palbociclib Ribociclib Seliciclib ^†) PrI Bortezomib Carfilzomib Oprozomib Ixazomib PhI (Anagrelide) IMPDI (Tiazofurin ^§) LI (Masoprocol) PARP inhibitor (Fuzuloparib Niraparib +abiraterone acetate Olaparib Rucaparib) HDAC (Belinostat Entinostat Panobinostat Romidepsin Vorinostat) PIKI (Pi3K) (Alpelisib Copanlisib ^‡ Duvelisib Idelalisib Inavolisib Umbralisib ^‡) IDH (Enasidenib Ivosidenib Olutasidenib Vorasidenib)
Receptor antagonists	ERA (Atrasentan) Retinoid X receptor (Bexarotene) Sex steroid (Testolactone)
Other/ungrouped	Adagrasib Aflibercept Arsenic trioxide Asparagine depleters (Asparaginase ^#/Pegaspargase) Axicabtagene ciloleucel Belzutifan Bexarotene Brexucabtagene autoleucel Celecoxib Ciltacabtagene autoleucel Demecolcine Denileukin diftitox Eflornithine Elesclomol ^§ Elsamitrucin Epacadostat Eribulin Estramustine Glasdegib Idecabtagene vicleucel Imetelstat Lifileucel Lisocabtagene maraleucel Lonidamine Lucanthone Lurbinectedin Mitoguazone Mitotane Nadofaragene firadenovec Navitoclax Obecabtagene autoleucel Oblimersen ^† Omacetaxine mepesuccinate Plitidepsin Tabelecleucel Retinoids (Alitretinoin Tretinoin ^#) Selinexor Sitimagene ceradenovec Sotorasib Tagraxofusp Talimogene laherparepvec Tazemetostat Tebentafusp Tiazofurine Tigilanol tiglate Tisagenlecleucel Trabectedin Veliparib Venetoclax Verdinexor Vosaroxin

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

v
t
e

Retrieved from "https://en.wikipedia.org/w/index.php?title=Vosaroxin&oldid=1230934872"